DGAT1 is identified as a key immunometabolic regulator of macrophage pyroptosis and targeting DGAT1 may represent a potential therapeutic strategy to mitigate Kp infection-induced macrophage pyroptosis and is suggested to represent a potential therapeutic strategy to mitigate Kp infection-induced macrophage pyroptosis.
Abstract
Klebsiella pneumoniae
(Kp) is a Gram-negative opportunistic pathogen that causes severe infections, including pneumonia and sepsis, yet the molecular mechanisms governing macrophage cell death during Kp infection are incompletely understood. Here, we identify diacylglycerol acyltransferase-1 (DGAT1) as a critical regulator of macrophage pyroptosis during infection with a classical Kp (cKp) isolate. cKp infection induced lipid droplet (LD) accumulation in murine macrophages, whereas pharmacological inhibition or genetic suppression of DGAT1 attenuated LD formation and pyroptotic cell death. Mechanistically, DGAT1-dependent LD accumulation was associated with lysosomal dysfunction and mitochondrial reactive oxygen species (ROS) production, which together facilitated NLRP3 inflammasome activation and pyroptosis. Furthermore, LD accumulation, ROS production, and mTOR signaling were mutually interconnected, as inhibition of any one component attenuated the others, collectively sustaining pyroptotic signaling during cKp infection. Small RNA sequencing further identified miR-155-5p as a ROS-dependent microRNA up-regulated during cKp infection, which promoted LD accumulation in a DGAT1-dependent manner and contributed to pyroptotic cell death. Collectively, these findings identify DGAT1 as a key immunometabolic regulator of macrophage pyroptosis and suggest that targeting DGAT1 may represent a potential therapeutic strategy to mitigate Kp infection-induced macrophage pyroptosis.
MSM alleviates lethal MRSA infection by enhancing macrophage phagocytosis and promoting NO production to eliminate intracellular bacteria, position MSM as a promising therapeutic agent against drug-resistant bacterial infections, offering a novel strategy for managing sepsis.
Hao-Ru Liu, Wan-Qi Tang, Hongsheng Zheng et al.· Life Science· 0 citations
Klebsiella pneumoniae is a major cause of multidrug-resistant and hypervirulent infections worldwide, highlighting the urgent need for host-directed therapeutic strategies that complement conventional antibiotics. Emerging evidence suggests that K. pneumoniae promotes intracellular persistence by suppressing host SUMOy...
It is hypothesized that TMEM175 deficiency exacerbates sepsis by impairing CTSD activity, and TMEM175 expression was significantly downregulated in PBMCs from septic patients.
Zhen-Zhen Bai, Bei Peng, Tao Luo et al.· Journal of Immunological Res...· 0 citations
This study is the first to characterize the dynamics of KP infection in porcine lungs at single-cell resolution and advances the understanding of KP-host interactions and provides a framework for anti-KP therapeutic development.
BACKGROUND
In critically ill patients, sepsis can precipitate acute lung injury (ALI), a syndrome with high incidence in intensive care settings. Pyroptosis plays an important role in ALI, highlighting its potential as a drug target. The NLRP3-mediated classical pyroptosis pathway is notably implicated in this pathogen...
Tian-Yu Kong, Xiao-Yue He, Zi-Xian Yin et al.· International Immunopharmaco...· 0 citations
Findings identify CUL4B as a regulator of MΦ inflammatory responses during MRSA infection and suggest a potential host-directed pathway that could be leveraged to improve outcomes against this major pathogen.
Fatemeh Askarian, Daniel Sun, Jasmine Tat et al.· Science Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.